Ponikwicka-Tyszko, D.; Chrusciel, M.; Pulawska, K.; Bernaczyk, P.; Sztachelska, M.; Guo, P.; Li, X.; Toppari, J.; Huhtaniemi, I.T.; Wołczyński, S.;
et al. Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice. Cancers 2020, 12, 3263.
https://doi.org/10.3390/cancers12113263
AMA Style
Ponikwicka-Tyszko D, Chrusciel M, Pulawska K, Bernaczyk P, Sztachelska M, Guo P, Li X, Toppari J, Huhtaniemi IT, Wołczyński S,
et al. Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice. Cancers. 2020; 12(11):3263.
https://doi.org/10.3390/cancers12113263
Chicago/Turabian Style
Ponikwicka-Tyszko, Donata, Marcin Chrusciel, Kamila Pulawska, Piotr Bernaczyk, Maria Sztachelska, Peilan Guo, Xiangdong Li, Jorma Toppari, Ilpo T. Huhtaniemi, Slawomir Wołczyński,
and et al. 2020. "Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice" Cancers 12, no. 11: 3263.
https://doi.org/10.3390/cancers12113263
APA Style
Ponikwicka-Tyszko, D., Chrusciel, M., Pulawska, K., Bernaczyk, P., Sztachelska, M., Guo, P., Li, X., Toppari, J., Huhtaniemi, I. T., Wołczyński, S., & Rahman, N. A.
(2020). Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice. Cancers, 12(11), 3263.
https://doi.org/10.3390/cancers12113263